Ergomed (ERGO)

1,505.00
+55.00(+3.79%)
  • Volume:
    57,786
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    1,405.00 - 1,510.00

ERGO Overview

Prev. Close
1,450
Day's Range
1,405-1,510
Revenue
102.05M
Open
1,405
52 wk Range
720.2-1,571
EPS
0.24
Volume
57,786
Market Cap
736M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
64,525
P/E Ratio
61.30
Beta
0.53
1-Year Change
77.91%
Shares Outstanding
48,903,631
Next Earnings Date
23 Mar 2022
What is your sentiment on Ergomed?
or
Market is currently closed. Voting is open during market hours.

Ergomed News

Ergomed Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Ergomed Company Profile

Ergomed Company Profile

Employees
1009

Ergomed plc is a provider of drug development services to the pharmaceutical industry. The Company operates through two segments: clinical research services (CRS), and drug safety and medical information services (DS&MI). It provides a range of clinical trial planning, management and monitoring services. It is focused on oncology, neurology and immunology, and the development of orphan drugs. It has two businesses: Services Business and Co-Development Business. The Services Business is a clinical research business providing services to the pharmaceutical and biotechnology industry. The Co-Development Business is a portfolio of partnerships with pharmaceutical and biotechnology companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including out licensing milestones, as well as sales of the product. It provides clinical development, trial management and pharmacovigilance services to over 100 clients.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.